Cannabis use among primary care patients with depression and anxiety disorders: cross-sectional analysis in a large health system in Los Angeles, CA.

This research study examined how common cannabis use is among primary care patients in Los Angeles who have depression and/or anxiety disorders. The researchers looked at data from a large health system to understand the relationship between mental health conditions, psychiatric medications, cannabis use, and the risk of developing cannabis use disorder (CUD)—a condition where someone struggles to control their cannabis use despite negative consequences. This is an important question because depression, anxiety, and cannabis use are all becoming more prevalent in the general population, yet many healthcare systems don't systematically ask patients about their cannabis use.

The study compared patients with different mental health profiles: those with depression, those with anxiety, those with both conditions, and those without either disorder. Researchers also looked at how this related to whether patients were taking psychiatric medications. By conducting a cross-sectional analysis (a snapshot at one point in time) in a large Los Angeles health system, they aimed to identify patterns and risk factors that could help doctors better understand and support their patients who use cannabis and have mental health concerns.

The findings have significant practical implications for primary care doctors, patients, and public health. Understanding the overlap between mental health conditions and cannabis use can help healthcare providers have more informed conversations with patients about their substance use, identify those at higher risk for cannabis use disorder, and make better treatment recommendations. This type of research is crucial because many people self-medicate depression and anxiety with cannabis, and doctors need current data to guide evidence-based care.